110 related articles for article (PubMed ID: 4031383)
1. Differential effects of acute DA receptor blockade with domperidone on LH and TSH release in patients with hyperprolactinemia.
Peters JR; Rodriguez-Arnao MD; Foord SM; Edwards C; Dieguez C; Woodhead S; Hall R; Scanlon MF
J Endocrinol Invest; 1985 Apr; 8(2):163-6. PubMed ID: 4031383
[TBL] [Abstract][Full Text] [Related]
2. Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect.
Rodriguez-Arnao MD; Peters JR; Foord SM; Dieguez C; Edwards C; Gomez-Pan A; Hall R; Newcombe RG; Scanlon MF
J Clin Endocrinol Metab; 1983 Nov; 57(5):975-80. PubMed ID: 6619271
[TBL] [Abstract][Full Text] [Related]
3. Catecholamines and pituitary function. VII: Effects of acute and chronic dopamine-receptor blockade on pituitary response to TRH-GNRH in normal women and in patients with hyperprolactinemic amenorrhea.
Giammartino C; Ambrosi F; Pelicci G; Pagliacci MC; Fedeli L; Nicoletti I
Horm Metab Res; 1988 Jan; 20(1):44-8. PubMed ID: 3131222
[TBL] [Abstract][Full Text] [Related]
4. Thyrotropin alpha- and beta-subunit responses to thyrotropin-releasing hormone and domperidone in normal subjects and in patients with microprolactinomas.
Persani L; Beck-Peccoz P; Medri G; Conti A; Faglia G
Neuroendocrinology; 1991 Apr; 53(4):411-5. PubMed ID: 1710792
[TBL] [Abstract][Full Text] [Related]
5. Dissociated response of thyrotropin and prolactin to dopamine receptor blockade with domperidone in hypothyroid subjects.
Marcondes JA; Santomauro AT; Minanni SL; Wajchenberg BL
Horm Metab Res; 1991 Dec; 23(12):605-8. PubMed ID: 1778595
[TBL] [Abstract][Full Text] [Related]
6. On the role of dopamine receptors in the central regulation of human TSH.
Delitala G; Devilla L; Canessa A; D'Asta F
Acta Endocrinol (Copenh); 1981 Dec; 98(4):521-7. PubMed ID: 7304078
[TBL] [Abstract][Full Text] [Related]
7. Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function.
Scanlon MF; Rodriguez-Arnao MD; McGregor AM; Weightman D; Lewis M; Cook DB; Gomez-Pan A; Hall R
Clin Endocrinol (Oxf); 1981 Feb; 14(2):133-43. PubMed ID: 6790201
[TBL] [Abstract][Full Text] [Related]
8. Prolactin and thyrotropin response to blockade of dopamine synthesis by monoiodotyrosine in subjects with postpartum and pathological hyperprolactinemia.
Ghigo E; Ciccarelli E; Novelli A; Massobrio M; Müller EE; Camanni F
J Endocrinol Invest; 1985 Feb; 8(1):35-40. PubMed ID: 3989236
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal pattern of the TSH and PRL responses to dopamine receptor blockade in women with physiological or pathological hyperprolactinaemia.
Massara F; Camanni F; Martra M; Dolfin GC; Müller EE; Molinatti GM
Clin Endocrinol (Oxf); 1983 Feb; 18(2):103-10. PubMed ID: 6851194
[TBL] [Abstract][Full Text] [Related]
10. Prolactin and TSH responses to both domperidone and TRH in normal and hyperprolactinaemic women after dopamine synthesis blockade.
Ghigo E; Goffi S; Molinatti GM; Camanni F; Massara F
Clin Endocrinol (Oxf); 1985 Aug; 23(2):155-60. PubMed ID: 3931942
[TBL] [Abstract][Full Text] [Related]
11. Luteinizing hormone response to domperidone in hyperprolactinaemic women with pituitary microadenomas.
Seki K; Kato K
Clin Endocrinol (Oxf); 1988 Mar; 28(3):271-5. PubMed ID: 3048796
[TBL] [Abstract][Full Text] [Related]
12. Differential TSH and PRL responses to dopamine receptor blockade in acromegaly.
Prescott RW; Weightman DR; Kendall-Taylor P; Johnston DG
Clin Endocrinol (Oxf); 1984 Oct; 21(4):369-75. PubMed ID: 6509782
[TBL] [Abstract][Full Text] [Related]
13. The extracerebral dopamine antagonist domperidone block the suppressive effect of bromocriptine on prolactin and TSH secretion in man.
Svet-Moldavsky I; Svet-Moldavsky G; Zinzar S; Holland J; Vergara C; Arlin Z; Koziner B; Clarkson B
Biomedicine; 1981 Oct; 35(5):142-4. PubMed ID: 6797487
[TBL] [Abstract][Full Text] [Related]
14. TSH and prolactin responses to thyrotropin releasing hormone (TRH) and domperidone in patients with empty sella syndrome.
Valensi P; Combes ME; Perret G; Attali JR
J Endocrinol Invest; 1996 May; 19(5):293-7. PubMed ID: 8796337
[TBL] [Abstract][Full Text] [Related]
15. The influence of oestrogens on the sensitivity of PRL, TSH and LH to the inhibitory actions of dopamine in hyperprolactinaemic patients.
Valcavi R; Harris PE; Foord SM; Dieguez C; Evans PJ; Peters JR; Hall R; Scanlon MF
Clin Endocrinol (Oxf); 1985 Aug; 23(2):139-46. PubMed ID: 4053412
[TBL] [Abstract][Full Text] [Related]
16. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R
Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
[TBL] [Abstract][Full Text] [Related]
17. Relation between luteinizing hormone and prolactin pulses in ovariectomized rats with or without dopamine inhibition.
Pohl CR; Weiner RI; Smith MS
Endocrinology; 1988 Sep; 123(3):1591-7. PubMed ID: 3402398
[TBL] [Abstract][Full Text] [Related]
18. Effect of domperidone on prolactin (PRL)and thyrotrophin (TSH) secretion.
Kaufman JM; Elewaut A; Vermeulen A
Arch Int Pharmacodyn Ther; 1981 Dec; 254(2):293-303. PubMed ID: 6802092
[TBL] [Abstract][Full Text] [Related]
19. Domperidone, an extracerebral inhibitor of dopamine receptors, stimulates thyrotropin and prolactin release in man.
Delitala G; Devilla L; Lotti G
J Clin Endocrinol Metab; 1980 Jun; 50(6):1127-30. PubMed ID: 7372791
[TBL] [Abstract][Full Text] [Related]
20. The acute effects of a dopamine antagonist (domperidone) on luteinising hormone, follicule stimulating hormone, prolactin and thyrotrophin secretion in polycystic ovarian syndrome: differential effect of ovulation.
Murdoch AP; Dunlop W; Kendall-Taylor P; Watson MJ
Clin Endocrinol (Oxf); 1984 Dec; 21(6):611-9. PubMed ID: 6439439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
